Newsroom

DUBLIN--(BUSINESS WIRE)--AV Laboratories, producent klinicznych rozwiązań ukierunkowanych na długowieczność skóry, łączący zaawansowane receptury naukowe z innowacjami w dziedzinie pielęgnacji skóry, ma przyjemność przekazać informację o udziale w konferencji Aesthetic & Regenerative Medicine Conference w dniach 18–19 października 2026 r. w obiekcie Croke Park (Dublin). Marka dołączy do Regenivus, wyspecjalizowanej w medycynie estetycznej marki zależnej Mitrone Healthcare Ltd., ugruntowaneg...

WASHINGTON--(BUSINESS WIRE)--Ifrah Law announced that a federal court in Virginia held the non-compete and non-solicitation provisions in sports agency Octagon's employment contract unenforceable under Virginia law. The court’s ruling not only invalidated Virginia-based Octagon’s restrictive covenants, finding them overly broad and violative of Virginia law, but also found Octagon liable for violation of California law. In reaching this conclusion, the Court upheld and enforced California law d...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, a global leader in women’s health, today announced that it has signed a definitive agreement to acquire Reveal Genomics, a precision oncology company based in Barcelona, Spain, that develops advanced genomic diagnostic tests to help personalized cancer treatment, including its HER2DX test to help optimize therapy for patients with HER2-positive breast cancer. Breast cancer remains one of the most significant health challenges women face today. Revea...

CINCINNATI--(BUSINESS WIRE)--ProAmpac, a global leader in flexible packaging and material science, introduces ProActive Intelligence™ Shelf Protect (SP) Series, giving food producers a new way to help preserve product quality and reduce costly spoilage. Designed for select meat, seafood, and dairy applications, the technology is FDA- and USDA-compliant for intended uses in fresh beef, fresh pork, cooked sausage, deli meat, fresh salmon, and fresh cheese. This direct food-contact biotechnology p...

NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AAA to the Dormitory Authority of New York State State Personal Income Tax Revenue Bonds (General Purpose), Series 2026C (Tax-Exempt) and affirms the long-term rating of AAA for the State's outstanding State Personal Income Tax Revenue Bonds. The rating Outlook is Stable. Key Credit Considerations The rating actions reflect the following key credit considerations: Credit Positives Provisions of the PIT Enabling Act and the importance...

LOS ANGELES--(BUSINESS WIRE)--FMC Investors with $100,000 in Losses Have Opportunity to Join FMC Corporation Fraud Investigation with SBS Law...

NEW YORK--(BUSINESS WIRE)--Extel, the leading provider of market sentiment in the financial industry, has today announced the results of its 2026 All-America Research Team survey, with J.P. Morgan maintaining their leading position by total published positions. Now in its 55th year, this independent survey determines the best-in-class sell-side research teams in the U.S. and gives buy-side investors a structured way to assess the research they use. The full results and accompanying editorial ca...

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) today announced that Krista Lee Berger has joined the company as Senior Vice President, Global Marketing, Clinique. Clinique is one of the most trusted, iconic brands in the world providing dermatologist guided solutions that are allergy tested, 100% fragrance free. In this role, Krista will lead Clinique’s new global marketing strategies while accelerating breakthrough innovation and putting the brand in culture through mode...

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against D-Wave Quantum Inc. (D-Wave) (NASDAQ: QBTS) on behalf of those who purchased or acquired D-Wave securities between February 26, 2026 and August 25, 2026, inclusive. The lawsuit is filed in the United States District Court for the Northern District of California and is cap...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced results from a study evaluating an AI-enabled pre-screening panel for patients with advanced non-small cell lung cancer (NSCLC). The panel achieved greater than 80% sensitivity across all 12 biomarkers assessed, with sensitivity exceeding 90% for several biomarkers, supporting its potential to identify patients who may need confirmatory biomarker testing. Results from the study will be presented at the European Society for...